• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同多发性硬化症表型认知研究中的饶氏简短可重复成套测验:塞尔维亚人群中常模数据的应用

The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

作者信息

Dackovic Jelena, Pekmezovic Tatjana, Mesaros Sarlota, Dujmovic Irena, Stojsavljevic Nebojsa, Martinovic Vanja, Drulovic Jelena

机构信息

Clinic of Neurology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 6, Belgrade, 11000, Serbia.

Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

出版信息

Neurol Sci. 2016 Sep;37(9):1475-81. doi: 10.1007/s10072-016-2610-1. Epub 2016 May 20.

DOI:10.1007/s10072-016-2610-1
PMID:27207679
Abstract

Cognitive impairment is prevalent in multiple sclerosis (MS) occurring in 43-72 % of patients with all MS phenotypes. The aim of our study was to assess cognitive performance in different MS subtypes in Serbian population. Rao's Brief Repeatable Battery of neuropsychological tests (BRB-N) was administered to 168 MS patients [37 patients with clinically isolated syndrome (CIS) suggestive of MS, 65 with relapsing-remitting MS (RRMS), 31 with secondary progressive MS (SPMS) and 35 patients with primary progressive MS (PPMS)]. The percentage of cognitively impaired patients in our total MS cohort was 58.9 %. Prevalence of cognitive dysfunction was 40.5 % in CIS group, 36.9 % in RRMS, 96.8 % in SPMS, and 85.7 % in PPMS group. Patients in CIS and RRMS groups performed consistently better all tests of the Rao's battery than patients in SPMS and PPMS cohort. CIS and RRMS groups performed consistently better in all tests of the Rao's battery than SPMS and PPMS cohort. Additionally, difference in the performance of any of the BRB-N tests was not found between CIS and RRMS. However, there was a significant difference between SPMS and PPMS patients in the performance on five tests of Rao's battery. Statistical significance (p < 0.05) in favor of PPMS patients was demonstrated for the following tasks: SRT_lts, SRT_cltr, SDMT, SRT_D, SPART_D. Our study demonstrates that cognitive impairment is frequent in all MS phenotypes. Furthermore, we have found that cognitive deficit is most severe and most frequent in SPMS patients, followed by PPMS subjects and then CIS and RRMS patients.

摘要

认知障碍在多发性硬化症(MS)中很常见,所有MS表型的患者中有43%-72%会出现认知障碍。我们研究的目的是评估塞尔维亚人群中不同MS亚型的认知表现。对168名MS患者进行了Rao简短可重复神经心理测验组合(BRB-N)[37例临床孤立综合征(CIS)提示为MS的患者,65例复发缓解型MS(RRMS)患者,31例继发进展型MS(SPMS)患者和35例原发进展型MS(PPMS)患者]。我们整个MS队列中认知受损患者的比例为58.9%。CIS组认知功能障碍的患病率为40.5%,RRMS组为36.9%,SPMS组为96.8%,PPMS组为85.7%。CIS组和RRMS组的患者在Rao测验组合的所有测试中的表现始终优于SPMS组和PPMS队列中的患者。CIS组和RRMS组在Rao测验组合的所有测试中的表现始终优于SPMS组和PPMS队列。此外,未发现CIS组和RRMS组在任何BRB-N测试的表现上存在差异。然而,SPMS组和PPMS组患者在Rao测验组合的五项测试表现上存在显著差异。在以下任务中显示出有利于PPMS患者的统计学显著性(p<0.05):SRT_lts、SRT_cltr、SDMT、SRT_D、SPART_D。我们的研究表明,认知障碍在所有MS表型中都很常见。此外,我们发现认知缺陷在SPMS患者中最为严重和常见,其次是PPMS患者,然后是CIS和RRMS患者。

相似文献

1
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.不同多发性硬化症表型认知研究中的饶氏简短可重复成套测验:塞尔维亚人群中常模数据的应用
Neurol Sci. 2016 Sep;37(9):1475-81. doi: 10.1007/s10072-016-2610-1. Epub 2016 May 20.
2
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.在繁忙的多发性硬化症临床环境中检测认知功能障碍:一种计算机生成的方法。
Eur J Neurol. 2014 Feb;21(2):281-6. doi: 10.1111/ene.12292. Epub 2013 Nov 7.
3
Assessment of cognition using the Rao's Brief Repeatable Battery of Neuropsychological Tests on a group of Brazilian patients with multiple sclerosis.使用饶氏简短可重复神经心理测验电池组对一组巴西多发性硬化症患者进行认知评估。
Arq Neuropsiquiatr. 2011 Dec;69(6):887-91. doi: 10.1590/s0004-282x2011000700007.
4
Cognitive impairment and decline in different MS subtypes.不同多发性硬化症亚型中的认知障碍与衰退
J Neurol Sci. 2006 Jun 15;245(1-2):187-94. doi: 10.1016/j.jns.2005.07.018. Epub 2006 Apr 27.
5
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.作为多发性硬化症认知障碍筛查工具的简短版饶氏简易可重复成套测验
Clin Neuropsychol. 2009 Feb;23(2):268-75. doi: 10.1080/13854040801992815.
6
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.复发缓解型、继发进展型和原发进展型多发性硬化症认知障碍的差异。
Neurology. 2004 Jul 27;63(2):335-9. doi: 10.1212/01.wnl.0000129828.03714.90.
7
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.饶氏简短可重复成套测验和斯特鲁普测验:意大利人群中按年龄、教育程度和性别校正的常模值
Mult Scler. 2006 Dec;12(6):787-93. doi: 10.1177/1352458506070933.
8
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.复发缓解型多发性硬化轻度残疾患者的认知障碍及其与疾病指标的关系:多发性硬化认知障碍(COGIMUS)研究的基线结果
Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544.
9
[Normalization of the Brief Repeatable Battery of Neuropsychological tests (BRB-N) for German-speaking regions. Application in relapsing-remitting and secondary progressive multiple sclerosis patients].[德语区简短可重复神经心理测试组合(BRB-N)的标准化。在复发缓解型和继发进展型多发性硬化症患者中的应用]
Nervenarzt. 2004 Oct;75(10):984-90. doi: 10.1007/s00115-004-1729-0.
10
Multiple sclerosis by phenotype in Germany.德国基于表型的多发性硬化症。
Mult Scler Relat Disord. 2022 Jan;57:103326. doi: 10.1016/j.msard.2021.103326. Epub 2021 Oct 10.

引用本文的文献

1
Prevalence of cognitive impairment (CI) in patients with multiple sclerosis (MS): A systematic review and meta-analysis.多发性硬化症(MS)患者认知障碍(CI)的患病率:一项系统评价和荟萃分析。
Caspian J Intern Med. 2024 Summer;15(3):392-413. doi: 10.22088/cjim.15.3.392.
2
Cognitive impairment in multiple sclerosis: "classic" knowledge and recent acquisitions.多发性硬化中的认知障碍:“经典”知识与最新进展。
Arq Neuropsiquiatr. 2023 Jun;81(6):585-596. doi: 10.1055/s-0043-1763485. Epub 2023 Jun 28.
3
Cognitive Imapirment in Multiple Sclerosis: Relation to Dysability, Duration and Type of Disease.

本文引用的文献

1
Cognitive performance profile in different phenotypes of MS with cognitive complaints.伴有认知障碍的不同表型多发性硬化症患者的认知表现概况
Mult Scler Relat Disord. 2014 Jul;3(4):463-72. doi: 10.1016/j.msard.2014.01.003. Epub 2014 Jan 24.
2
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.多发性硬化症认知功能障碍的临床和影像评估。
Lancet Neurol. 2015 Mar;14(3):302-17. doi: 10.1016/S1474-4422(14)70250-9. Epub 2015 Feb 4.
3
Defining the clinical course of multiple sclerosis: the 2013 revisions.多发性硬化症临床病程的定义:2013年修订版
多发性硬化症中的认知障碍:与残疾、病程及疾病类型的关系
Mater Sociomed. 2023 Mar;35(1):23-27. doi: 10.5455/msm.2023.35.23-27.
4
VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS.在一个大样本的复发缓解型多发性硬化症(RRMS)患者队列中验证简短国际认知评估多发性硬化症测试(BICAMS)。
Acta Clin Croat. 2022 Mar;61(1):62-69. doi: 10.20471/acc.2022.61.01.08.
5
Integrated Cognitive Rehabilitation Home-Based Protocol to Improve Cognitive Functions in Multiple Sclerosis Patients: A Randomized Controlled Study.基于家庭的综合认知康复方案改善多发性硬化症患者的认知功能:一项随机对照研究。
J Clin Med. 2022 Jun 20;11(12):3560. doi: 10.3390/jcm11123560.
6
Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype.继发进展型多发性硬化症中的认知障碍:病程、年龄和进展表型的影响
Brain Sci. 2022 Jan 29;12(2):183. doi: 10.3390/brainsci12020183.
7
Identifying Early Neuropsychological Indicators of Cognitive Involvement in Multiple Sclerosis.识别多发性硬化症认知受累的早期神经心理学指标。
Neuropsychiatr Dis Treat. 2021 Feb 5;17:323-337. doi: 10.2147/NDT.S256689. eCollection 2021.
8
The Expanded Disability Status Scale Score and Demographic Indexes Are Correlated with the Severity of Cognitive Impairment in Multiple Sclerosis Patients.扩展残疾状态量表评分和人口统计学指标与多发性硬化症患者认知障碍的严重程度相关。
J Clin Neurol. 2021 Jan;17(1):113-120. doi: 10.3988/jcn.2021.17.1.113.
9
Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA.在临床实践中对接受西尼莫德治疗的继发进展型多发性硬化症患者的初步洞察:非干预性研究AMASIA方案
JMIR Res Protoc. 2020 Jul 24;9(7):e19598. doi: 10.2196/19598.
10
Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis.多发性硬化症相关性功能障碍的流行病学、诊断与管理。
Acta Neurol Belg. 2020 Aug;120(4):791-797. doi: 10.1007/s13760-020-01323-4. Epub 2020 Mar 11.
Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28.
4
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.脑储备和认知储备可预防 MS 患者在 4.5 年内认知能力下降。
Neurology. 2014 May 20;82(20):1776-83. doi: 10.1212/WNL.0000000000000433. Epub 2014 Apr 18.
5
Cognitive impairment differs between primary progressive and relapsing-remitting MS.认知障碍在原发性进行性和复发缓解型多发性硬化症之间有所不同。
Neurology. 2013 Apr 16;80(16):1501-8. doi: 10.1212/WNL.0b013e31828cf82f. Epub 2013 Mar 20.
6
Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.认知障碍与复发性缓解型多发性硬化症的非躯体性抑郁症状密切相关。
Arch Clin Neuropsychol. 2013 Mar;28(2):144-55. doi: 10.1093/arclin/acs113. Epub 2013 Jan 4.
7
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.简短重复电池测验:在塞尔维亚人群中进行年龄、教育和性别校正的心理计量学和常模值。
Neurol Sci. 2012 Dec;33(6):1369-74. doi: 10.1007/s10072-012-1099-5. Epub 2012 May 3.
8
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).多发性硬化症简短国际认知评估建议(BICAMS)。
Mult Scler. 2012 Jun;18(6):891-8. doi: 10.1177/1352458511431076. Epub 2011 Dec 21.
9
Cognition in multiple sclerosis.多发性硬化症的认知功能障碍。
Curr Opin Neurol. 2011 Jun;24(3):244-9. doi: 10.1097/WCO.0b013e328346a43b.
10
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.多发性硬化症的诊断标准:2010 年麦克唐纳标准修订版。
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.